Jingding Pharmaceutical strengthens clinical data and digital service capabilities through important appointments

Former GSK executive Stephen Pyke will lead the implementation and development of Jingding Pharmaceutical’s clinical data and digital strategy to better utilize data insights to support Jingding Pharmaceutical’s “patient-centric” strategic focus

Shanghai, October 12, 2021/PRNewswire/ - Parexel, a leading multinational clinical research organization (CRO) dedicated to the development and delivery of innovative therapies to improve human health, recently announced the appointment of Stephen Pyke is the executive vice president of clinical data and digital services

Dr.

Before joining Jing Ding Pharmaceutical, Pyke worked at GlaxoSmithKline as a senior vice president and head of digital data analysis and development

The new clinical data and digital service team integrates the existing functions of Jingding Medicine, including scientific data organization, global data operation, real-world evidence and scientific data technology

During the COVID-19 pandemic, Jingding Pharmaceutical found that it is becoming more and more important to listen to the voices of patients and fully understand the needs of patients, whether in traditional randomized controlled clinical trials or in real-world studies to collect data

About Jingding Pharmaceutical

Jing Ding Pharmaceutical is committed to supporting the development of innovative drugs to improve the health of patients

Source: Jing Ding Pharmaceutical